Skip to content

Explore different blood pressure control strategies for pregnancy based on simulated RCT Clinical study of adverse maternal-fetal outcomes in non-severe hypertensive pregnant women

Explore different blood pressure control strategies for pregnancy based on simulated RCT Clinical study of adverse maternal-fetal outcomes in non-severe hypertensive pregnant women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400095014
Enrollment
Unknown
Registered
2024-12-31
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive disorder complicating pregnancy

Interventions

Tight control:NA
Loose control:NA

Sponsors

Shanghai First Maternity and Infant Health Hospital (Tongji University Affiliated Obstetrics and Gynecology Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: The presence of elevated blood pressure at 14 weeks 0 days to 33 weeks 6 days of gestation, office diastolic blood pressure of 90 to 105 mmHg (85 to 105 mmHg if taking antihypertensive drugs).

Exclusion criteria

Exclusion criteria: Systolic blood pressure =160 mmHg (subsequent inclusion if systolic blood pressure < 160 mmHg after treatment and all other eligibility criteria are met), diagnosis of proteinuria, use of angiotensin-converting enzyme (ACE) inhibitors at 14 weeks 0 days of gestation and beyond, preconception diabetes or kidney disease, need for delivery due to maternal or fetal reasons, multiple pregnancies, The fetus has a severe abnormality or chromosomal abnormality, has a plan to terminate the pregnancy, and has participated in CHIPS.

Design outcomes

Primary

MeasureTime frame
Composite primary outcomes include pregnancy loss (miscarriage, ectopic pregnancy, pregnancy termination, stillbirth, or neonatal death) or the need for a high level of neonatal care for more than 48 hours within 28 days of birth;

Secondary

MeasureTime frame
eclampsia;HELLP syndromne;placental abruption;intra uterine fetal death;fetal growth restriction;neonatal septicemia;

Countries

China

Contacts

Public ContactXiaolin Hua

Shanghai First Maternity and Infant Health Hospital (Tongji University Affiliated Obstetrics and Gynecology Hospital)

huaxiaolin_sh@163.com+86 189 3050 2621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026